A Phase 2, Double-blind, Placebo-controlled Study of the Safety and Tolerability of Etanercept in Patients With Alzheimer's Disease.

Trial Profile

A Phase 2, Double-blind, Placebo-controlled Study of the Safety and Tolerability of Etanercept in Patients With Alzheimer's Disease.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 May 2015

At a glance

  • Drugs Etanercept (Primary)
  • Indications Alzheimer's disease; Dementia
  • Focus Adverse reactions
  • Acronyms STEADI-09
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 May 2015 Results published in the Neurology.
    • 22 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top